missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human SH3BP2 (aa 352-434) Control Fragment Recombinant Protein
Click to view available options
Quantity:
100 μL
Unit Size:
100µL
Description
Highest antigen sequence indentity to the following orthologs: Mouse (78%), Rat (78%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-144770 (PA5-144770. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
The protein encoded by this gene has an N-terminal pleckstrin homology (PH) domain, an SH3-binding proline-rich region, and a C-terminal SH2 domain. The protein binds to the SH3 domains of several proteins including the ABL1 and SYK protein tyrosine kinases, and functions as a cytoplasmic adaptor protein to positively regulate transcriptional activity in T, natural killer (NK), and basophilic cells. Mutations in this gene result in cherubism. Multiple transcript variants encoding different isoforms have been found for this gene.
Specifications
Specifications
| Accession Number | P78314 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 6452 |
| Name | Human SH3BP2 (aa 352-434) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | 3 BP2; 3 BP-2; Abl-SH3 binding protein 2; CRBM; CRPM; FLJ42079; LOW QUALITY PROTEIN: SH3 domain-binding protein 2; RES4-23; SH3 domain binding protein 2; SH3 domain-binding protein 2; SH3BP2; SH3-domain binding protein 2; TNFAIP3 interacting protein 2 |
| Common Name | SH3BP2 |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction